Abbott Builds Up Diabetes Business With TheraSense Acquisition
This article was originally published in The Tan Sheet
Executive Summary
Access to a development partnership with insulin infusion pump manufacturer Smiths Medical may be a critical component of Abbott Labs' $1.2 bil. purchase of diabetes management firm TheraSense